Total Payments
$37,644
2024 Payments
$9,631
Companies
6
Transactions
94
Medicare Patients
2,910
Medicare Billing
$206,384
Payment Breakdown by Category
Other$32,905 (87.4%)
Food & Beverage$2,542 (6.8%)
Travel$2,197 (5.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $32,905 | 17 | 87.4% |
| Food and Beverage | $2,542 | 67 | 6.8% |
| Travel and Lodging | $2,197 | 10 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $37,009 | 82 | $0 (2024) |
| United Therapeutics Corporation | $240.58 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $194.01 | 2 | $0 (2022) |
| Merck Sharp & Dohme LLC | $106.93 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $57.46 | 3 | $0 (2022) |
| GENZYME CORPORATION | $36.07 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,631 | 13 | Actelion Pharmaceuticals US, Inc. ($9,343) |
| 2023 | $8,129 | 14 | Actelion Pharmaceuticals US, Inc. ($8,070) |
| 2022 | $5,309 | 12 | Actelion Pharmaceuticals US, Inc. ($5,182) |
| 2021 | $4,086 | 9 | Actelion Pharmaceuticals US, Inc. ($4,045) |
| 2020 | $137.84 | 2 | GlaxoSmithKline, LLC. ($120.00) |
| 2019 | $6,345 | 27 | Actelion Pharmaceuticals US, Inc. ($6,345) |
| 2018 | $3,956 | 14 | Actelion Pharmaceuticals US, Inc. ($3,956) |
| 2017 | $49.85 | 3 | Actelion Pharmaceuticals US, Inc. ($49.85) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $88.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/14/2024 | United Therapeutics Corporation | REMODULIN (Drug), ORENITRAM, TYVASO | Food and Beverage | In-kind items and services | $54.50 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 05/09/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,540.00 | General |
| Category: Cardiology | ||||||
| 04/29/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Travel and Lodging | Cash or cash equivalent | $544.52 | General |
| Category: Cardiology | ||||||
| 04/27/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: Cardiology | ||||||
| 04/27/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Cardiology | ||||||
| 04/27/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiology | ||||||
| 04/27/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiology | ||||||
| 04/26/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Travel and Lodging | In-kind items and services | $195.38 | General |
| Category: Cardiology | ||||||
| 04/24/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,090.00 | General |
| Category: Cardiology | ||||||
| 04/01/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Travel and Lodging | In-kind items and services | $727.39 | General |
| Category: Cardiology | ||||||
| 03/07/2024 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $105.31 | General |
| 02/27/2024 | United Therapeutics Corporation | ORENITRAM (Drug), Steen Solution, REMODULIN | Food and Beverage | In-kind items and services | $146.00 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 10/10/2023 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $40.08 | General |
| 09/26/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $18.69 | General |
| 09/21/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Cardiology | ||||||
| 07/05/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,030.00 | General |
| Category: Cardiology | ||||||
| 06/29/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $149.04 | General |
| Category: Cardiology | ||||||
| 05/17/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,010.00 | General |
| Category: Cardiology | ||||||
| 05/03/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,030.00 | General |
| Category: Cardiology | ||||||
| 04/25/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Cardiology | ||||||
| 04/13/2023 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $139.28 | General |
| 03/25/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Cardiology | ||||||
| 03/24/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Cardiology | ||||||
| 03/02/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $505.00 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 472 | 668 | $125,390 | $51,292 |
| 2022 | 12 | 979 | 1,171 | $126,283 | $50,115 |
| 2021 | 13 | 713 | 948 | $154,731 | $62,326 |
| 2020 | 12 | 746 | 874 | $128,084 | $42,652 |
Total Patients
2,910
Total Services
3,661
Medicare Billing
$206,384
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 148 | 249 | $33,756 | $18,010 | 53.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 29 | 76 | $40,584 | $12,754 | 31.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 45 | 64 | $14,944 | $7,165 | 47.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 73 | 86 | $8,599 | $3,912 | 45.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 27 | $6,831 | $2,542 | 37.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 16 | 16 | $4,288 | $2,141 | 49.9% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 14 | 19 | $5,320 | $1,600 | 30.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 14 | 14 | $2,789 | $1,298 | 46.6% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 11 | 12 | $3,948 | $941.92 | 23.9% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 30 | 31 | $961.00 | $283.20 | 29.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 30 | 31 | $1,364 | $242.40 | 17.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 30 | 31 | $806.00 | $209.40 | 26.0% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 12 | 12 | $1,200 | $192.61 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 131 | 218 | $28,830 | $15,152 | 52.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 28 | 61 | $31,598 | $10,331 | 32.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 36 | 55 | $13,114 | $5,893 | 44.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 94 | 115 | $11,289 | $5,604 | 49.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 26 | 26 | $5,044 | $2,638 | 52.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 26 | $6,370 | $2,074 | 32.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 193 | 198 | $5,940 | $1,859 | 31.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 193 | 198 | $8,316 | $1,594 | 19.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 11 | 11 | $2,871 | $1,574 | 54.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 193 | 198 | $4,950 | $1,379 | 27.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 23 | $3,887 | $1,281 | 32.9% |
| 94618 | Test for exercise-induced lung stress | Facility | 2022 | 40 | 42 | $4,074 | $737.46 | 18.1% |
About Bianca Monteiro
Bianca Monteiro is a Critical Care Medicine healthcare provider based in Dover, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1467615013.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bianca Monteiro has received a total of $37,644 in payments from pharmaceutical and medical device companies, with $9,631 received in 2024. These payments were reported across 94 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($32,905).
As a Medicare-enrolled provider, Monteiro has provided services to 2,910 Medicare beneficiaries, totaling 3,661 services with total Medicare billing of $206,384. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Pulmonary Disease
- Location Dover, NH
- Active Since 07/03/2008
- Last Updated 02/17/2020
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1467615013
Products in Payments
- UPTRAVI (Drug) $25,997
- OPSUMIT (Drug) $554.16
- OPSUMIT MACITENTAN (Drug) $194.53
- TRELEGY ELLIPTA (Drug) $194.01
- ORENITRAM (Drug) $146.00
- WINREVAIR (Biological) $88.24
- REMODULIN (Drug) $54.50
- BREZTRI (Drug) $40.51
- DUPIXENT (Biological) $36.07
- TEZSPIRE (Biological) $16.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Dover
David Jawahar, Md, MD
Critical Care Medicine — Payments: $9,947
Critical Care Medicine $9,947
Shannon Cullin, Np, NP
Critical Care Medicine — Payments: $4,281
Critical Care Medicine $4,281
Deborah Warshawsky, Crnp, CRNP
Critical Care Medicine — Payments: $1,625
Critical Care Medicine $1,625
Dr. David Reeves, M.d, M.D
Critical Care Medicine — Payments: $1,607
Critical Care Medicine $1,607
Margarita Gianniosis
Critical Care Medicine — Payments: $1,111
Critical Care Medicine $1,111
Dr. Dhruv Desai, M.d, M.D
Critical Care Medicine — Payments: $654.98
Critical Care Medicine $654.98